Article Per Year (5 Year)
p-Index From 2021 - 2026
0.23
P-Index
This Author published in this journals
All Journal International Journal of Accounting, Management, Economics and Social Sciences (IJAMESC)
Fajar Maully Pratama
Unknown Affiliation
Humanities Economics, Econometrics & Finance Education Law, Crime, Criminology & Criminal Justice Social Sciences

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
STRATEGIC BUSINESS SYNERGY IN HEALTH SERVICES: ANALYSIS OF THE DEVELOPMENT OF GF RANCABOLANG (GF RCB) PHARMACY AND DOCTOR CLINIC Fajar Maully Pratama; Yenny Maya Dora
International Journal of Accounting, Management, Economics and Social Sciences (IJAMESC) Vol. 4 No. 1 (2026): February
Publisher : ZILLZELL MEDIA PRIMA

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61990/ijamesc.v4i1.687

Abstract

This business plan aims to analyze the financial feasibility and development prospects of the GF Rancabolang Pharmacy and Medical Clinic (GF RCB) as an integrated health service (one-stop service) that combines medical practice and medicine provision. This plan was developed based on the increasing community need for accessible, fast, and high-quality health services. The analysis was conducted using a quantitative approach through investment feasibility indicators, namely Payback Period, Net Present Value (NPV), Return on Investment (ROI), and Profitability Index (PI). The results of the calculations show that the initial investment of IDR 540,000,000 is feasible. The Payback Period was achieved in 1.26 years (±15 months), indicating a quick return on investment. The NPV value of IDR 526,859,000 shows that the project generates positive economic benefits, while the ROI of 79% and PI of 1.98 prove that this venture provides a high level of profit. The 2025–2029 financial projections show an increase in revenue from IDR 2.2billion to IDR 3.22 billion, as well as an increase in net profit after tax from IDR 429 million to IDR 761 million. Thus, the development of the GF Rancabolang Pharmacy and Clinics declared feasible, profitable, and has long-term growth prospects.
Co-Authors Yenny Maya Dora